Premium Nahrungsergänzungsmittel | artgerecht

Coagulation – Blood Clotting Explained

Coagulation is the process by which blood transforms from a liquid into a solid clot. This vital mechanism stops bleeding after blood vessel injuries and is essential for survival.

Regular tips about health Regular tips about health

Things worth knowing about "Coagulation"

Coagulation is the process by which blood transforms from a liquid into a solid clot. This vital mechanism stops bleeding after blood vessel injuries and is essential for survival.

What is Coagulation?

Coagulation (from Latin coagulatio = clotting) is the biochemical process by which blood transitions from a liquid to a solid state. It is a core component of hemostasis – the body´s natural mechanism to stop bleeding – and protects the body from excessive blood loss following injury to blood vessels.

Coagulation involves a complex interplay between proteins known as clotting factors, blood platelets (thrombocytes), and the vascular endothelium. The process unfolds in a series of sequential steps, ultimately resulting in the formation of a stable fibrin clot.

Mechanism of Coagulation

The coagulation process is classically divided into two pathways that converge on a common final pathway:

Extrinsic Pathway (Tissue Factor Pathway)

This pathway is triggered when tissue factor (Factor III) is released after vascular injury. It forms a complex with Factor VII, initiating a cascade that rapidly leads to thrombin generation. This pathway responds quickly and is crucial for the initial coagulation response.

Intrinsic Pathway (Contact Activation Pathway)

This pathway is initiated when blood comes into contact with negatively charged surfaces, such as exposed collagen following endothelial damage. It is slower than the extrinsic pathway but essential for sustaining and amplifying the coagulation process.

Common Final Pathway

Both pathways converge at the activation of Factor X, which together with Factor V forms the prothrombinase complex. This complex converts prothrombin (Factor II) into active thrombin. Thrombin then cleaves fibrinogen into fibrin, which polymerizes into a stable, insoluble network that reinforces the clot.

Role of Platelets

Alongside plasma-based coagulation, platelets play a critical role. Following vascular injury, platelets adhere to the damaged site (adhesion), activate one another (activation), and clump together (aggregation), forming a primary platelet plug. Fibrin formation subsequently stabilizes this plug.

Regulation of Coagulation

To prevent uncontrolled clotting throughout the bloodstream, the body relies on natural anticoagulant mechanisms, including:

Antithrombin: Inhibits thrombin and other clotting factors
Protein C and Protein S: Inactivate Factors Va and VIIIa
TFPI (Tissue Factor Pathway Inhibitor): Inhibits the extrinsic pathway

In addition, the fibrinolytic system dissolves clots after wound healing, with plasmin playing the central role in this process.

Clinical Relevance

Disorders of coagulation can occur in two directions:

Clotting Deficiency (Hypocoagulability)

A deficiency in clotting factors or platelets leads to an increased tendency to bleed. Well-known conditions include:

Hemophilia A and B: Deficiency of Factor VIII or Factor IX, respectively
Von Willebrand Disease: Deficiency or dysfunction of von Willebrand factor
Thrombocytopenia: Reduced platelet count

Excessive Clotting (Hypercoagulability)

An excessive tendency to clot leads to the formation of unwanted blood clots (thromboses), which can cause serious complications such as pulmonary embolism or stroke. Risk factors include genetic defects (e.g., Factor V Leiden mutation), immobilization, pregnancy, or certain medications.

Diagnosis

Various laboratory tests are used to assess coagulation function:

Prothrombin Time (PT) / INR: Evaluates the extrinsic pathway and common final pathway
aPTT (Activated Partial Thromboplastin Time): Evaluates the intrinsic pathway
Platelet Count: Assesses the quantity of platelets
Fibrinogen Level: Measures available fibrinogen
D-Dimers: Indicate prior coagulation activation and fibrinolysis

Treatment of Coagulation Disorders

Treatment approaches vary depending on the type of disorder:

Anticoagulants (e.g., heparin, vitamin K antagonists, direct oral anticoagulants): Suppress clotting in patients at risk of thrombosis
Clotting factor concentrates: Used as replacement therapy in hemophilia or other factor deficiencies
Platelet transfusions: Administered in severe thrombocytopenia
Thrombolytics (e.g., alteplase): Dissolve existing clots in acute myocardial infarction or stroke

References

Hoffman R et al. - Hematology: Basic Principles and Practice, 7th Edition. Elsevier, Philadelphia 2018.
Levi M, van der Poll T - Coagulation and sepsis. Thrombosis Research, 2017; 149: 38-44. Available at: https://pubmed.ncbi.nlm.nih.gov
World Health Organization (WHO) - Guidelines on the management of clinical problems in haemophilia. WHO, Geneva 2020. Available at: https://www.who.int

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category